tiprankstipranks
Advertisement
Advertisement
Johnson & Johnson presents exploratory analyses from DAHLIAS study
PremiumThe FlyJohnson & Johnson presents exploratory analyses from DAHLIAS study
3d ago
Johnson & Johnson announces nipocalimab met primary endpoint in JASMINE study
Premium
The Fly
Johnson & Johnson announces nipocalimab met primary endpoint in JASMINE study
3d ago
Medline Stock (MDLN) Sinks on FDA Warning over Production Practices
Premium
Market News
Medline Stock (MDLN) Sinks on FDA Warning over Production Practices
3d ago
J&J reports updated results from Phase 1/1b CHRYSALIS-2 study
PremiumThe FlyJ&J reports updated results from Phase 1/1b CHRYSALIS-2 study
7d ago
Johnson & Johnson reports new data from Phase 3 MajesTEC-9 study
Premium
The Fly
Johnson & Johnson reports new data from Phase 3 MajesTEC-9 study
8d ago
J&J says FDA approves Tremfya label expansion
Premium
The Fly
J&J says FDA approves Tremfya label expansion
8d ago
Johnson & Johnson Stock Forecast: Trending Bullish Among Analysts
PremiumAnalystsJohnson & Johnson Stock Forecast: Trending Bullish Among Analysts
21d ago
Davis to become acting director of CDER after Hoeg exit, Bloomberg says
Premium
The Fly
Davis to become acting director of CDER after Hoeg exit, Bloomberg says
21d ago
Johnson & Johnson Stock Forecast: Trending Upgrade From Top Analyst
Premium
Analysts
Johnson & Johnson Stock Forecast: Trending Upgrade From Top Analyst
23d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100